Collegium Pharmaceutical (COLL) Total Debt (2014 - 2026)
Collegium Pharmaceutical (COLL) posted quarterly Total Debt of $564.3 million for Q1 2026, up 0.73% year-over-year from $560.3 million in Q1 2025, and down 1.18% quarter-over-quarter from $571.1 million in Q4 2025.
Collegium Pharmaceutical (COLL) Total Debt (2014 - 2026) Analysis & Trends
Collegium Pharmaceutical's Total Debt history runs 13 years deep, the most recent figure standing at $564.3 million for Q1 2026.
- In Q1 2026, Total Debt rose 0.73% year-over-year to $564.3 million; the TTM figure through Mar 2026 stood at $564.3 million (up 0.73% YoY), while the FY2025 annual figure was $571.1 million, down 7.18% from the prior year.
- Total Debt for Q1 2026 stood at $564.3 million, down from $571.1 million in the prior quarter.
- The five-year high for Total Debt was $630.3 million in Q3 2024, with the low at $316.2 million in Q2 2024.
- The 5-year median for Total Debt is $560.3 million (2025), against an average of $527.7 million.
- The sharpest annual moves came in 2022 and 2024: Total Debt jumped 409.07% in 2022, then tumbled 35.9% in 2024.
- Collegium Pharmaceutical's Total Debt stood at $560.1 million in 2022, then retreated by 27.68% to $405.0 million in 2023, then surged by 51.91% to $615.3 million in 2024, then dropped by 7.18% to $571.1 million in 2025, then declined by 1.18% to $564.3 million in 2026.
- Business Quant data shows COLL's Total Debt at $564.3 million in Q1 2026, $571.1 million in Q4 2025, and $505.6 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Debt (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.91 Bn | 42.95 Bn | - | -5.81 Bn |
| 2 | Teva Pharmaceutical Industries | 43.07 Bn | 39.42 Bn | 2.15 Bn | 16.59 Bn |
| 3 | Zoetis | 31.54 Bn | 29.86 Bn | 1.05 Bn | 9.05 Bn |
| 4 | Takeda Pharmaceutical | 28.61 Bn | 22.81 Bn | 5.10 Bn | 31.47 Bn |
| 5 | United Therapeutics | 22.19 Bn | 19.53 Bn | 683.80 Mn | - |
| 6 | Viatris | 18.68 Bn | 17.79 Bn | 1.46 Bn | 13.35 Bn |
| 7 | Neurocrine Biosciences | 15.50 Bn | 15.11 Bn | 935.80 Mn | - |
| 8 | Elanco Animal Health | 11.76 Bn | 11.23 Bn | 798.00 Mn | 3.92 Bn |
| 9 | Dr Reddys Laboratories | 10.12 Bn | 9.96 Bn | - | 760.00 Mn |
| 10 | Collegium Pharmaceutical | 889.49 Mn | 740.17 Mn | 110.29 Mn | 852.82 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 852.82 Mn |
| Mar 31, 2026 | 564.35 Mn |
| Dec 31, 2025 | 571.11 Mn |
| Sep 30, 2025 | 505.60 Mn |
| Jun 30, 2025 | 585.23 Mn |
| Mar 31, 2025 | 560.26 Mn |
| Dec 31, 2024 | 615.32 Mn |
| Sep 30, 2024 | 630.30 Mn |
| Jun 30, 2024 | 316.18 Mn |
| Mar 31, 2024 | 360.69 Mn |
| Dec 31, 2023 | 405.05 Mn |
| Sep 30, 2023 | 449.22 Mn |
| Jun 30, 2023 | 493.23 Mn |
| Mar 31, 2023 | 537.10 Mn |
| Dec 31, 2022 | 560.08 Mn |
| Sep 30, 2022 | 582.93 Mn |
| Jun 30, 2022 | 605.69 Mn |
| Mar 31, 2022 | 628.39 Mn |
| Dec 31, 2021 | 110.02 Mn |
| Sep 30, 2021 | 121.97 Mn |